Related Experiment Videos
[A case of scirrhous gastric cancer responding to TS-1/CDDP neoadjuvant chemotherapy]
Shinichiro Kameyama1, Ryota Murayama, Keiko Miyazato
1Dept. of Surgery, Urasoe General Hospital.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|April 14, 2006
Abstract:
A 72-year-old female with scirrhous-type advanced gastric cancer was treated with TS-1/CDDP as neoadjuvant chemotherapy. TS-1 (80 mg/m(2)/day) was orally administered for 3 weeks and CDDP (60 mg/m(2)) was administered by intravenous drip on day 8. Partial response (PR) was obtained after the first course, and total gastrectomy was performed. The histological diagnosis revealed complete disappearance of cancer cells in the stomach and a few regional lymph node metastases (3/67). The patient has now been in good health without a recurrence for 1 year and 9 months after surgery.